Ex Parte Sydora et alDownload PDFPatent Trial and Appeal BoardSep 26, 201713323328 (P.T.A.B. Sep. 26, 2017) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 211012US00 (4081-11700) 7725 EXAMINER QIAN, YUN ART UNIT PAPER NUMBER 1732 MAIL DATE DELIVERY MODE 13/323,328 12/12/2011 Orson L. Sydora 37814 7590 09/26/2017 CHEVRON PHILLIPS CHEMICAL COMPANY 5601 Granite Parkway, Suite 500 PLANO, TX 75024 09/26/2017 PAPER Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte ORSON L. SYDORA, RONALD D. KNUDSEN, and EDUARDO J. BARALT Appeal 2016-008184 Application 13/323,328 Technology Center 1700 Before JAMES C. HOUSEL, CHRISTOPHER L. OGDEN, and MERRELL C. CASHION, JR., Administrative Patent Judges. HOUSEL, Administrative Patent Judge. DECISION ON APPEAL1 Pursuant to 35 U.S.C. § 134(a), Appellants2 appeal from the Examiner’s decision finally rejecting claims 1, 5, 9, 12, 13, 15, 16, 19, and 1 Our decision refers to the Specification (Spec.) filed December 12, 2011, the Examiner’s Final Office Action dated September 4, 2015, Appellants’ Appeal Brief (Appeal Br.) filed February 4, 2016, the Examiner’s Answer (Ans.) dated July 8, 2016, and Appellants’ Reply Brief (Reply Br.) filed September 1, 2016. 2 According to Appellants, the real party in interest is Chevron Phillips Chemical Company, LP. Appeal Br. 3. Appeal 2016-008184 Application 13/323,328 20 under 35 U.S.C. § 102(b) as anticipated by Knudsen.3 We have jurisdiction over the appeal under 35 U.S.C. § 6(b). We REVERSE. STATEMENT OF THE CASE The invention relates to an olefin oligomerization catalyst. Spec., Title. Appellants disclose one widely employed ethylene trimerization catalyst system comprises a chromium carboxylate, a pyrrole compound, and a metal alkyl. Spec. 12. Appellants disclose as one example of such a known system Cr(III)tris(2-ethylhexanoate), 2,5-dimethylpyrrole, triethylaluminum, and diethylaluminum chloride. Id. However, according to Appellants, batch-to-batch variations in the quality of commercial Cr(III)tris(2-ethylhexanoate) and the attendant inconsistency in catalytic system performance, which can have significant impacts upon ethylene trimerization productivity and selectivity. Id. ^3. Thus, Appellants disclose it would be useful to develop new catalyst systems and methods of making them that might improve the trimerization process efficiency and cost effectiveness. Id. Claim 1, reproduced below from the Claims Appendix to the Appeal Brief, is illustrative of the subject matter on appeal. 1. A composition comprising: a) a chromium(III) C3—C25 carboxylate composition i) having a KBr pellet infrared spectrum with a DaSym (CO2) infrared absorbance peak within 110 cm'1 of the Oasym (CO2) infrared peak and having an infrared 3 Knudsen et al., US 2007/0043181 Al, published February 22, 2007 (“Knudsen”). 2 Appeal 2016-008184 Application 13/323,328 absorbance peak height ratio of a nasym (CO2) infrared absorbance peak at 1516 ± 15 cm'1 to infrared absorbance peak located at 700 ± 50 cm'1 greater than or equal to 3:1, ii) having a goodness of fit test value, R2, of at least 0.6 when comparing high-energy X-ray diffraction g(r) data points of the chromium(III) C3—C25 carboxylate composition to calculated high energy X-ray diffraction g(r) data points of a theoretical model of mononuclear chromium(HI) acetate over an r range from 1.3 Angstroms to 4 Angstroms, or iii) produced by a process comprising contacting under substantially anhydrous and substantially acid-free conditions 1) a chromium(III) precursor having a formula CrX^ L/ where each X independently is a halide, each L independently is a C2-C10 ether, a C2-C10 thioether, a C2-C5 nitrile, a C1-C30 amine, or a C3-C30 phosphine, or any combination thereof, and £ ranges from 0 to 7, 2) a Group 1 or Group 2 metal C3-C25 carboxylate, and 3) a first solvent; b) a pyrrole compound; and c) a metal hydrocarbyl compound. ANALYSIS The dispositive issue before us in this appeal is whether Appellants have identified reversible error in the Examiner’s finding that Knudsen teaches the same composition as recited in claim 1. Appellants argue that the composition of Knudsen, in particular the Cr(III)tris(2-ethylhexanoate) disclosed in Knudsen, is different from that required in claim 1 because of 3 Appeal 2016-008184 Application 13/323,328 differences in the processes of making these chromium carboxylates and differences in their infrared (IR) spectral data. Appeal Br. 7—9; Reply Br. 4— 8. For the reasons set forth below and in the Appeal and Reply Briefs, we are persuaded that the composition as recited in claim 1 is not the same composition disclosed in Knudsen. Accordingly, we will not sustain the Examiner’s anticipation rejection. The Examiner finds that Knudsen teaches the composition of claim 1 because Knudsen teaches a composition comprising Cr(III)tris(2- ethylhexanoate), 2,5-dimethylpyrrole, triethylaluminum, and diethylaluminum chloride. Final Act. 3. This is the same composition Appellants admit was known. Spec. 12. The Examiner acknowledges that Appellants’ Cr(III)tris(2-ethylhexanoate) is made by a different process from Knudsen’s Cr(III)tris(2-ethylhexanoate). Final Act. 4. However, the Examiner notes that claim 1 recites the process by which the chromium carboxylate is made as an alternative within the claim and, citing In re Thorpe, 111 F.2d 695, 697 (Fed. Cir. 1985) and In re Marosi, 710 F.2d 799, 803 (Fed. Cir. 1983), shifts the burden to Appellants to come forward with evidence establishing an unobvious difference between the claimed product and Knudsen ’ s. Id. Appellants note that the Examiner finds the claimed product and that of Knudsen are made by different processes. Appeal Br. 7. Appellants’ urge that the products made by these different processes are not the same products as exemplified by their different IR spectra. Id. at 9. In particular, Appellants contend that Knudsen’s IR spectra differ from Appellants’ in that Knudsen’s IR spectra do not show a peak at 1516 ± 15 cm-1 as shown in Appellants’ Figures 10, 12, and 14. As such, as Appellants argue, the 4 Appeal 2016-008184 Application 13/323,328 Examiner has not provided a rationale tending to show that the claimed product appears to be the same as Knudsen’s. We are mindful that the Examiner relies on the product-by-process limitation for the Cr(III)tris(2-ethylhexanoate) (claim l(a)(iii)) rather than the IR spectral limitation or the X-ray diffraction data limitation to support the anticipation rejection. However, merely because Appellants recite the product in product-by-process language does not relieve the burden on the Examiner to establish a reasonable basis for believing that the products of the claim and the prior art are the same. Particularly in a case such as this, where the processes are different and there is evidence within the prior art teaching and the disclosure that demonstrates that the resulting products are not the same, the Examiner cannot shift the burden to Appellants without articulating a rationale based on technical reasoning or evidence in the record why the products are nonetheless likely to be the same. DECISION Upon consideration of the record, and for the reasons given above and in the Appeal and Reply Briefs, the decision of the Examiner rejecting claims 1, 5, 9, 12, 13, 15, 16, 19, and 20 under 35 U.S.C. § 102(b) as anticipated by Knudsen is reversed. REVERSED 5 Copy with citationCopy as parenthetical citation